Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ricardo Titze-de-Almeida

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Pharmaceutics|August 26, 2023
Progress in circRNA-Targeted Therapy in Experimental Parkinson's DiseaseSimoneide Souza Titze-de-Almeida, Ricardo Titze-de-Almeida
Current Gene Therapy|May 2, 2018
miR-7 Replacement Therapy in Parkinson's DiseaseRicardo Titze-de-Almeida, Simoneide Souza Titze-de-Almeida
Pharmaceutical Research|April 9, 2017
The Race of 10 Synthetic RNAi-Based Drugs to the Pharmaceutical MarketRicardo Titze-de-Almeida, Catherine David, Simoneide Souza Titze-de-Almeida
Applied and Environmental Microbiology|April 7, 2006
Absence of VanA- and VanB-containing enterococci in poultry raised on nonintensive production farms in BrazilDiego Batista Xavier, Francisco Ernesto Moreno Bernal, Ricardo Titze-de-Almeida
Pharmaceutical Research|February 9, 2018
Correction to: The Race of 10 Synthetic RNAi-Based Drugs to the Pharmaceutical MarketRicardo Titze-de-Almeida, Catherine David, Simoneide Souza Titze-de-Almeida
Biomolecules|August 27, 2021
BRCAness as a Biomarker of Susceptibility to PARP Inhibitors in Glioblastoma MultiformeMary-Ann Xavier, Fernando Rezende, Ricardo Titze-de-Almeida, et al.
Molecular Medicine Reports|March 6, 2017
The involvement of Eag1 potassium channels and miR-34a in rotenone-induced death of dopaminergic SH-SY5Y cellsCamila Hillesheim Horst, Ricardo Titze-de-Almeida, Simoneide Souza Titze-de-Almeida
Oncology Letters|March 20, 2018
Function of neuronal nitric oxide synthase enzyme in temozolomide-induced damage of astrocytic tumor cellsFernando Francisco Borges Resende, Simoneide Souza Titze-de-Almeida, Ricardo Titze-de-Almeida
Anticancer Research|March 14, 2013
RNA interference with EAG1 enhances interferon gamma injury to glioma cells in vitroLudmylla Costa Cunha, Elaine Del Bel, Luis Pardo, et al.
Molecular Diagnosis & Therapy|December 4, 2019
Leading RNA Interference Therapeutics Part 2: Silencing Delta-Aminolevulinic Acid Synthase 1, with a Focus on GivosiranPedro Renato de Paula Brandão, Simoneide S Titze-de-Almeida, Ricardo Titze-de-Almeida
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Pharmaceutics|August 26, 2023
Progress in circRNA-Targeted Therapy in Experimental Parkinson's DiseaseSimoneide Souza Titze-de-Almeida, Ricardo Titze-de-Almeida
Current Gene Therapy|May 2, 2018
miR-7 Replacement Therapy in Parkinson's DiseaseRicardo Titze-de-Almeida, Simoneide Souza Titze-de-Almeida
Pharmaceutical Research|April 9, 2017
The Race of 10 Synthetic RNAi-Based Drugs to the Pharmaceutical MarketRicardo Titze-de-Almeida, Catherine David, Simoneide Souza Titze-de-Almeida
Applied and Environmental Microbiology|April 7, 2006
Absence of VanA- and VanB-containing enterococci in poultry raised on nonintensive production farms in BrazilDiego Batista Xavier, Francisco Ernesto Moreno Bernal, Ricardo Titze-de-Almeida
Pharmaceutical Research|February 9, 2018
Correction to: The Race of 10 Synthetic RNAi-Based Drugs to the Pharmaceutical MarketRicardo Titze-de-Almeida, Catherine David, Simoneide Souza Titze-de-Almeida
Biomolecules|August 27, 2021
BRCAness as a Biomarker of Susceptibility to PARP Inhibitors in Glioblastoma MultiformeMary-Ann Xavier, Fernando Rezende, Ricardo Titze-de-Almeida, et al.
Molecular Medicine Reports|March 6, 2017
The involvement of Eag1 potassium channels and miR-34a in rotenone-induced death of dopaminergic SH-SY5Y cellsCamila Hillesheim Horst, Ricardo Titze-de-Almeida, Simoneide Souza Titze-de-Almeida
Oncology Letters|March 20, 2018
Function of neuronal nitric oxide synthase enzyme in temozolomide-induced damage of astrocytic tumor cellsFernando Francisco Borges Resende, Simoneide Souza Titze-de-Almeida, Ricardo Titze-de-Almeida
Anticancer Research|March 14, 2013
RNA interference with EAG1 enhances interferon gamma injury to glioma cells in vitroLudmylla Costa Cunha, Elaine Del Bel, Luis Pardo, et al.
Molecular Diagnosis & Therapy|December 4, 2019
Leading RNA Interference Therapeutics Part 2: Silencing Delta-Aminolevulinic Acid Synthase 1, with a Focus on GivosiranPedro Renato de Paula Brandão, Simoneide S Titze-de-Almeida, Ricardo Titze-de-Almeida
Pageof 4